* Helius Medical Technologies Inc HSDT.OQ HSDT.O is
expected
to show a rise in quarterly revenue when it reports results on
November 7 (estimated) for the period ending September 30 2024
* The Newtown Pennsylvania-based company is expected to
report a
4.9% increase in revenue to $150 thousand from $143 thousand a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Helius Medical
Technologies
Inc is for a loss of $1.06 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated November 6 at 14:00 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)